Crossmark

Oral nicotinamide mononucleotide (NMN) increases tissue NAD+ content in mice but neither NMN nor Polypodium leucotomos protect against UVR-induced skin cancer

Crossref DOI link: https://doi.org/10.1007/s43630-025-00736-5

Published Online: 2025-05-29

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pihl, Celina https://orcid.org/0000-0002-0848-9096
Kara, Rozarin Delal https://orcid.org/0009-0003-7017-0232
Granborg, Jonatan Riber https://orcid.org/0000-0002-5887-630X
Olesen, Uffe Høgh https://orcid.org/0000-0002-4578-684X
Bjerring, Peter https://orcid.org/0000-0002-3031-1390
Haedersdal, Merete https://orcid.org/0000-0003-1250-2035
Untracht, Gavrielle R. https://orcid.org/0000-0001-6334-0625
Lerche, Catharina Margrethe https://orcid.org/0000-0003-3653-6424
Funding

Funding for this research was provided by:

Glashofs Legat

Købmand Inger Bonnens Fond

Tømrermester Jørgen Holm og Hustru Elisa F. Hansens Mindelegat

Copenhagen University
License Information

Text and Data Mining valid from 2025-05-29

Version of Record valid from 2025-05-29
More Information

Article History

Received: 17 March 2025

Accepted: 12 May 2025

First Online: 29 May 2025

Declarations

:

: The authors declare no competing interests.

: All experiments were approved by the Danish Animal Experiments Inspectorate (permit number 2021-15-0201-00905) and the local Institutional Animal Care and Use Committee located at Bispebjerg Hospital, Copenhagen, Denmark.

Document is current

Any future updates will be listed below